← FDA Drug Approvals (Drugs@FDA)

TEMSIROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2018-07-30

Drug application

FDA Application #

ANDA203153

Application type

Abbreviated New Drug Application (Generic)

Brand name

TEMSIROLIMUS

Generic name

TEMSIROLIMUS

Active ingredients

TEMSIROLIMUS

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACCORD HLTHCARE

Manufacturer

Accord Healthcare Inc.

First approval

2018-07-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown